Literature DB >> 17563647

In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time.

Bijan S Kheirabadi1, Jacqueline M Crissey, Rodolfo Deguzman, John B Holcomb.   

Abstract

BACKGROUND: The coagulopathy of trauma is generally confirmed by prothrombin time (PT) > or =16 seconds or an international normalized ratio > or =1.5. However, the utility of these values as a screening test is unknown. We examined different coagulation tests to determine the best predictor of coagulopathic bleeding and mortality in a small animal hemorrhage model.
METHODS: Coagulopathy was induced in male New Zealand White rabbits by warfarin (W; 2 mg/kg for 2 days; n = 7), or hemodilution and hypothermia (HH; 50% blood exchange with Hextend, 34.5 +/- 0.3 degrees C; n = 7). Normal (N) rabbits without pretreatment served as the control (n = 7). Blood samples collected after coagulopathy induction and analyzed by prothrombin time (PT), activated partial thromboplastin time (aPTT), and thromboelastography (TEG) tests. Liver bleeding time (BT) was also measured before injury. An uncontrolled hemorrhage was created by a longitudinal splenic incision and the abdomen was closed. Rabbits were resuscitated with Hextend solution (25 mL/kg) to return blood pressure to baseline and monitored for 2 hours or until death at which time blood loss was measured.
RESULTS: Warfarin-induced coagulopathy increased BT, PT, and aPTT. TEG showed increased reaction (R) and clot formation (K) times and marked decrease in clotting rate (alpha angle and Vmax). Hemodilution hypothermia coagulopathy increased only BT and aPTT, and decreased the clotting rate (alpha angle and Vmax) and strength of the clot. After injury, blood losses were higher in coagulopathic rabbits (W = 54.6 +/- 4.2 and HH = 51.1 +/- 8.9 mL/kg) than in normal rabbits (30.6 +/- 12.4 mL/kg) and resulted in 86%, 100%, and 0% death, respectively. BT and Vmax consistently predicted coagulopathic bleeding and death in all animals.
CONCLUSION: Although satisfactory in warfarin-induced coagulopathy, PT was not a valid screening test for dilutional and hypothermic coagulopathy. BT and TEG measurements of blood clotting rate are better indicators of coagulopathic bleeding and mortality in this lethal hemorrhage model.

Entities:  

Mesh:

Year:  2007        PMID: 17563647     DOI: 10.1097/TA.0b013e318047b805

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  21 in total

1.  Clotting factor deficiency in early trauma-associated coagulopathy.

Authors:  Sandro B Rizoli; Sandro Scarpelini; Jeannie Callum; Bartolomeu Nascimento; Kenneth G Mann; Ruxandra Pinto; Jan Jansen; Homer C Tien
Journal:  J Trauma       Date:  2011-11

2.  Pharmacokinetics and pharmacodynamics of SCT800, a new recombinant FVIII, in hemophilia A mice.

Authors:  Ruo-lan Gu; Liang Liu; Liang-zhi Xie; Wen-lin Gai; Si-shuo Cao; Zhi-yun Meng; Hui Gan; Zhuo-na Wu; Jian Li; Ying Zheng; Xiao-xia Zhu; Gui-fang Dou
Journal:  Acta Pharmacol Sin       Date:  2016-01-25       Impact factor: 6.150

Review 3.  Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography.

Authors:  Eduardo Gonzalez; Fredric M Pieracci; Ernest E Moore; Jeffry L Kashuk
Journal:  Semin Thromb Hemost       Date:  2010-10-26       Impact factor: 4.180

4.  Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis.

Authors:  Lucy Z Kornblith; Matthew E Kutcher; Brittney J Redick; Carolyn S Calfee; Ryan F Vilardi; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2014-02       Impact factor: 3.313

5.  Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation.

Authors:  Matthew F Whelihan; Armin Kiankhooy; Kathleen E Brummel-Ziedins
Journal:  J Crit Care       Date:  2013-10-29       Impact factor: 3.425

6.  Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.

Authors:  Jeffrey N Harr; Ernest E Moore; Arsen Ghasabyan; Theresa L Chin; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2013-01       Impact factor: 3.454

7.  Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.

Authors:  Herbert Schöchl; Ulrike Nienaber; Georg Hofer; Wolfgang Voelckel; Csilla Jambor; Gisela Scharbert; Sibylle Kozek-Langenecker; Cristina Solomon
Journal:  Crit Care       Date:  2010-04-07       Impact factor: 9.097

8.  Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury.

Authors:  Oliver Grottke; Till Braunschweig; Dietrich Henzler; Mark Coburn; Rene Tolba; Rolf Rossaint
Journal:  Crit Care       Date:  2010-04-14       Impact factor: 9.097

Review 9.  Resuscitation and transfusion principles for traumatic hemorrhagic shock.

Authors:  Philip C Spinella; John B Holcomb
Journal:  Blood Rev       Date:  2009-08-19       Impact factor: 8.250

Review 10.  Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.

Authors:  Pär I Johansson; Trine Stissing; Louise Bochsen; Sisse R Ostrowski
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-23       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.